$PPH News Wash, rinse and repeat the Wall Stre
Post# of 144482
Posted On: 04/18/2014 10:17:20 AM
$PPH News
Wash, rinse and repeat the Wall Street spin cycle 5:03 p.m. April 14, 2014 - Dave Fry
26 ways to profit from ‘Obamacare’ 7:01 a.m. Nov. 8, 2012 - The Trading Deck
How to play a post-election stock market 7:45 a.m. Nov. 6, 2012 - The Trading Deck
Obama or Romney, pharma is a loser 11:45 a.m. Aug. 15, 2012 - The Trading Deck
Therapeutic cloning breakthrough 1:30 p.m. April 17, 2014 - Seeking Alpha
New clinical trial format may boost cancer drug development 8:04 a.m. April 17, 2014 - Seeking Alpha
ModernGraham Annual Valuation Of Regeneron Pharmaceuticals 6:32 p.m. April 16, 2014 - Seeking Alpha
A Comprehensive Guide to Pharma ETFs - ETF News And Commentary 12:00 p.m. April 15, 2014 - Zacks.com
Nasdaq and Russell 2000 tumble more than 2% 1:12 p.m. April 4, 2014 - Seeking Alpha
ModernGraham Annual Valuation Of Amerisource Bergen 11:23 a.m. April 4, 2014 - Seeking Alpha
What If Merck Challenges Gilead Sciences In Hepatitis C Market? 4:52 p.m. March 27, 2014 - Seeking Alpha
3 Big Time Trends That ETF Investors May Miss 5:00 a.m. March 18, 2014 - InvestorPlace.com
3 Big Time Trends That ETF Investors May Miss 6:17 p.m. March 17, 2014 - Seeking Alpha
Pharma Patent Cliff: Why Worst Seems Over 7:08 p.m. Feb. 28, 2014 - Seeking Alpha
Health care sector at rare premium to consumer staples 12:35 p.m. Feb. 14, 2014 - Seeking Alpha
Northwest Is A Good Long-Term Bet 11:57 a.m. Feb. 14, 2014 - Seeking Alpha
Why La Jolla Pharma Has Very Favorable Risk/Reward 4:52 p.m. Feb. 5, 2014 - Seeking Alpha
The Acquisition Of Mills Pharmaceuticals Put Another Arrow In The Quiver Of Galena 7:07 p.m. Jan. 27, 2014 - Seeking Alpha
Seattle Genetics Will Exceed And Immunogen Will Meet Market Expectations 12:09 p.m. Jan. 25, 2014 - Seeking Alpha
Big Pharmas Battle For The Billion-Dollar Melanoma Market 7:42 p.m. Jan. 24, 2014 - Seeking Alpha
Private Customers Continue To Fuel Revenue Upside At Illumina 12:24 p.m. Jan. 21, 2014 - Seeking Alpha
All Signs Point To Geron's Imetelstat Being The Holy Grail Of Myeloproliferative Drugs 3:37 p.m. Jan. 17, 2014 - Seeking Alpha
AstraZeneca: Should You Buy This 4.5% Yielder? 12:56 p.m. Jan. 16, 2014 - Seeking Alpha
StemCells CEO Writes Letter To Shareholders, Identifies Upcoming Catalysts 3:14 p.m. Jan. 10, 2014 - Seeking Alpha
Wash, rinse and repeat the Wall Street spin cycle 5:03 p.m. April 14, 2014 - Dave Fry
26 ways to profit from ‘Obamacare’ 7:01 a.m. Nov. 8, 2012 - The Trading Deck
How to play a post-election stock market 7:45 a.m. Nov. 6, 2012 - The Trading Deck
Obama or Romney, pharma is a loser 11:45 a.m. Aug. 15, 2012 - The Trading Deck
Therapeutic cloning breakthrough 1:30 p.m. April 17, 2014 - Seeking Alpha
New clinical trial format may boost cancer drug development 8:04 a.m. April 17, 2014 - Seeking Alpha
ModernGraham Annual Valuation Of Regeneron Pharmaceuticals 6:32 p.m. April 16, 2014 - Seeking Alpha
A Comprehensive Guide to Pharma ETFs - ETF News And Commentary 12:00 p.m. April 15, 2014 - Zacks.com
Nasdaq and Russell 2000 tumble more than 2% 1:12 p.m. April 4, 2014 - Seeking Alpha
ModernGraham Annual Valuation Of Amerisource Bergen 11:23 a.m. April 4, 2014 - Seeking Alpha
What If Merck Challenges Gilead Sciences In Hepatitis C Market? 4:52 p.m. March 27, 2014 - Seeking Alpha
3 Big Time Trends That ETF Investors May Miss 5:00 a.m. March 18, 2014 - InvestorPlace.com
3 Big Time Trends That ETF Investors May Miss 6:17 p.m. March 17, 2014 - Seeking Alpha
Pharma Patent Cliff: Why Worst Seems Over 7:08 p.m. Feb. 28, 2014 - Seeking Alpha
Health care sector at rare premium to consumer staples 12:35 p.m. Feb. 14, 2014 - Seeking Alpha
Northwest Is A Good Long-Term Bet 11:57 a.m. Feb. 14, 2014 - Seeking Alpha
Why La Jolla Pharma Has Very Favorable Risk/Reward 4:52 p.m. Feb. 5, 2014 - Seeking Alpha
The Acquisition Of Mills Pharmaceuticals Put Another Arrow In The Quiver Of Galena 7:07 p.m. Jan. 27, 2014 - Seeking Alpha
Seattle Genetics Will Exceed And Immunogen Will Meet Market Expectations 12:09 p.m. Jan. 25, 2014 - Seeking Alpha
Big Pharmas Battle For The Billion-Dollar Melanoma Market 7:42 p.m. Jan. 24, 2014 - Seeking Alpha
Private Customers Continue To Fuel Revenue Upside At Illumina 12:24 p.m. Jan. 21, 2014 - Seeking Alpha
All Signs Point To Geron's Imetelstat Being The Holy Grail Of Myeloproliferative Drugs 3:37 p.m. Jan. 17, 2014 - Seeking Alpha
AstraZeneca: Should You Buy This 4.5% Yielder? 12:56 p.m. Jan. 16, 2014 - Seeking Alpha
StemCells CEO Writes Letter To Shareholders, Identifies Upcoming Catalysts 3:14 p.m. Jan. 10, 2014 - Seeking Alpha
(0)
(0)Scroll down for more posts ▼